|
|||||
|
Follow our Twitter feed of news and more! |
05/31/11 Beta-blockers – safe and inexpensive drugs used for 4 decades in the management of cardiovascular disease – have shown surprising promise in inhibiting breast cancer progression and metastasis. Two retrospective observational studies, published May 31 in Journal of Clinical Oncology, offer the latest evidence that the drugs, which have a role in neuroendocrine signaling pathways, [...] MARSEILLE, France, May 31, 2011 /PRNewswire-FirstCall/ — IPSOGEN SA (Alternext: ALIPS) today announces that two studies on the Genomic Grade test will be presented at the American Society for Clinical Oncology (ASCO) Annual Meeting, that will take place June 3-7, 2011, in Chicago, Ill, USA. The Genomic Grade test (GG), a multi-gene expression test, improves tumor grading, long [...] VICTORIA, Australia, May 31, 2011 /PRNewswire/ — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has received and processed its first BREVAGen™ clinical sample from a US patient. This follows last month’s receipt of certification of its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) (42 U.S.C. 263a). The sample was received by Phenogen Sciences, the Company’s [...] Published: Saturday, May 28, 2011, 22:15 IST A study has reported new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly discovered risk genes. Alfons Meindl of the Klinikum rechts der Isar (Munich) and co-authors evaluated data including those derived from the work of the German Consortium for Hereditary Breast [...] |
  |
|||
|
home - team - contact - donate |
|||||
